acute non-lymphocytic leukemia

急性非リンパ球性白血病

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 成人の急性骨髄性白血病の概要overview of acute myeloid leukemia in adults [show details]
  … topic will provide an overview of AML in adults. Further details about specific aspects of AML in adults are presented separately: AML arises as a consequence of various …
• 2. 急性骨髄性白血病の分類classification of acute myeloid leukemia [show details]
  … granulocytic, monocytic, erythroid, or megakaryocytic elements) AML has also been called acute myelogenous leukemia and acute non-lymphocytic leukemia. AML is characterized by a clonal proliferation of myeloid precursors …
• 3. 急性骨髄性白血病の臨床症状、病理学的特徴、および診断clinical manifestations pathologic features and diagnosis of acute myeloid leukemia [show details]
  … Acute myeloid leukemia (AML, also known as acute myelogenous leukemia) consists of a group of relatively well-defined hematopoietic neoplasms involving precursor cells committed to the myeloid line of …
• 4. 小児や青年の急性骨髄性白血病acute myeloid leukemia in children and adolescents [show details]
  …overview of AML in children and adolescents, focusing on issues that are of interest to primary care providers. The pathogenesis of AML and discussions of the molecular genetics and cytogenetics in AML are presented …
• 5. 急性骨髄性白血病：高齢患者への治療と転帰acute myeloid leukemia treatment and outcomes in older adults [show details]
  … therapy-related AML Special considerations for the use of chemotherapy in older patients Treatment of adults of any age with acute promyelocytic leukemia with t(15;17) (formerly known as FAB M3 AML) Older …

English Journal

• Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia.

• Tian YJ, Wang YH, Xiao AJ, Li PL, Guo J, Wang TJ, Zhao DJ.
• Artificial cells, nanomedicine, and biotechnology. 2019 Dec;47(1)1730-1737.
• LncRNA SBF2-AS1 has been reported to be implicated in the deterioration of multiple human cancers. However, the roles and underlying mechanisms of SBF2-AS1 in acute myeloid leukemia (AML) are still unclear. In the present study, the online GEPIA database showed that SBF2-AS1 expression was significa
• PMID 31062614

• Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.

• Owattanapanich W, Chayakulkeeree M.
• Hematology (Amsterdam, Netherlands). 2019 Dec;24(1)362-368.
• The incidence of febrile neutropenia (FN) in acute leukemia patients following induction or consolidation chemotherapy is high. Several clinical practice guidelines recommend the use of a fluoroquinolone prophylaxis to prevent bacterial infection in patients being prone to prolonged profound neutrop
• PMID 30880638

• ADAMTS-13 activity reduction in plasma of acute myeloid leukemia predicts poor prognosis after bone marrow transplantation.

• Liu C, Han M, Zhao L, Zhu M, Xu Q, Song Y, Wang H.
• Hematology (Amsterdam, Netherlands). 2019 Dec;24(1)129-133.
• This research aimed to explore the significance of low activity of ADAMTS-13 in acute myeloid leukemia (AML) after bone morrow transplantation (BMT), and to evaluate the disease progress and prognosis of the patients with low or normal activity of ADAMTS-13 after BMT. 46 AML patients were included i
• PMID 30322352

Japanese Journal

• Simultaneous expression of CD13, CD22 and CD25 is related to the expression of FcεR1 in non-lymphoid leukemia

• Sato Naoko,Kishi Kenji,Toba Ken,Watanabe Kenichi,Itoh Hiromi,Narita Miwako,Takahashi Masuhiro,Aizawa Yoshifusa,鳥羽 健
• Leukemia
• … Like CD19 or CD56, CD22 in non-lymphoid leukemia has been considered an aberrantly expressed antigen. … To estimate whether the expression of CD22 in non-lymphoid leukemia is aberrant or related to basophilic character, we analyzed 108 patients with primary and secondary leukemia. …
• NAID 120005324885

• Allogeneic CD34-selected peripheral stem cell transplant for acute non-lymphocytic leukemia (FAB M5a) developed from juvenile chronic myelogenous leukemia

• ONODERA Norio,ITO Ryosuke,TANAKA Hiroshi
• Pediatrics international : official journal of the Japan Pediatric Society 42(1), 106-108, 2000-02-01
• NAID 10009526560

• Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia

• DAMIANI D.
• Leukemia
• NAID 30014034217

Related Links

• Definition of Acute nonlymphocytic leukemia

Acute nonlymphocytic leukemia: Abbreviated ANLL. More commonly called acute myeloid leukemia (AML). A quickly progressive malignant disease in which there are too many immature blood-forming cells in the blood ...

• What Is Acute Lymphocytic Leukemia (ALL)? | Acute ...

Acute lymphocytic leukemia (ALL), also called acute lymphoblastic leukemia, is a cancer that starts from white blood cells called lymphocytes in the bone marrow. Skip to Content Menu Search Cancer Helpline 800.227.2345 ...

• Signs and Symptoms of Acute Lymphocytic Leukemia (ALL)

Acute lymphocytic leukemia (ALL) can cause many different signs and symptoms. Most of these occur in all kinds of ALL, but some are more common with certain subtypes of ALL. Symptoms caused by low numbers of ...

---

★リンクテーブル★

リンク元	「急性非リンパ球性白血病」「acute nonlymphocytic leukemia」「ANLL114qf」
関連記事	「acute」「n」「lymphocytic」「non」

「急性非リンパ球性白血病」

　　[★]

英

acute nonlymphocytic leukemia、acute nonlymphoblastic leukemia、acute nonlymphoid leukemia、acute non-lymphocytic leukemia、ANLL

関

急性骨髄性白血病、急性骨髄芽球性白血病、急性非リンパ性白血病

「acute nonlymphocytic leukemia」

　　[★] 急性非リンパ球性白血病 acute non-lymphocytic leukemia ANLL

「ANLL114qf」

　　[★]

同

acute non-lymphocytic leukemia

「acute」

　　[★]

• adj.

• (疾患)急性の、急性型の、急性的な。(形状が)鋭い、鋭角の。(感覚、才知などが)鋭い。明敏な、鋭い眼識のある。

関

acutely、quick、sharp

　 　 　 　 　 　

「n」

　　[★]

• n.

• 例数

関

number of experiment、sample size

• pの前の[n]はmと記載する。synptom→symptom

「lymphocytic」

　　[★]

• adj.

• リンパ球性の、リンパ性の、リンパ球系の

関

lymphatic

　

「non」

　　[★]

• comb form.

• 非

関

un